AUG 02, 2016 08:00 AM PDT

Reference Architectures for the QIAGEN Biomedical Genomics Solution

SPONSORED BY: Qiagen, Qiagen, Vert Clinical Leader
C.E. CREDITS: P.A.C.E. CE
Speakers
  • Senior Health & Life Sciences Solution Architect
    Biography
      Dr. Michael McManus joined Intel in the role of Senior Health & Life Sciences Solution Architect. He is part of Intel's effort to promote the use of modern computational solutions in the healthcare and life sciences markets. Dr. McManus joins Intel from Knome where he was the Senior Vice President of Operations and was the designer of the knoSYS hardware appliance for processing genomic data as part of the genome interpretation process used in a clinical setting. Dr. McManus has a 30-year history in the scientific software and hardware market in roles ranging from R&D to sales, including business development, marketing, product management, and executive management. Before Intel, Dr. McManus worked at six start-ups (CambridgeSoft, AnVil Informatics, GenomeQuest, TerraVerde BioWorks, Integromics, and Knome) and two public companies (Eastman Kodak, and Fujitsu Computer Systems).

      Dr. McManus received a B.S. in chemistry from the University of Massachusetts at Amherst and a Ph.D. in synthetic organic chemistry the Massachusetts Institute of Technology in Cambridge, MA. .
    • Director and solution lead for QIAGEN Bioinformatics
      Biography
        Mikael Flensborg, is a Director and solution lead for QIAGEN Bioinformatics (previously CLC Bio) High Volume Sequencing Solutions in Aarhus, Denmark. Mikael has over 30 years of combined experience in the software industry, from Bioinformatics software, architecture, servers to Developer Kit and has been instrumental in building strategic alliances and research collaborations for QIAGEN Bioinformatics

      Abstract:

      DATE: August 2, 2016
      TIME:  8:00 AM PST  11:00 AM  ET



      The combination of the QIAGEN Biomedical Genomics Solution with the Intel® Scalable System Framework and Intel’s extensive optimization efforts of life sciences software codes offers a new hardware architecture. This new architecture reduces the need for purpose-built systems and instead offers a more flexible and scalable architecture for genomics workloads. This webinar will briefly cover some of the recent code optimization activities, provide an overview of the Intel® Scalable System Framework then focus on some vendor specific examples of reference architectures for the QIAGEN Biomedical Genomics Solution, including some metrics for estimating the recommended cluster size based on the size of the genomic workload.


      Webinar (2) Learning Objectives:

      1. Learn about Intel’s efforts in its Code Optimization and Scalable System Framework
      2. Learn how to build your genomics cluster using products from common hardware companies; size your genomics cluster to meet your needs;  expand your cluster as your need grows.

       


      Show Resources
      You May Also Like
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      JUN 26, 2018 06:00 AM PDT
      C.E. CREDITS
      JUN 26, 2018 06:00 AM PDT
      Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      JUN 20, 2018 10:00 AM EDT
      C.E. CREDITS
      JUN 20, 2018 10:00 AM EDT
      DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
      SEP 12, 2017 08:00 AM PDT
      SEP 12, 2017 08:00 AM PDT
      DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
      AUG 30, 2018 11:00 AM EDT
      C.E. CREDITS
      AUG 30, 2018 11:00 AM EDT
      DATE: August 30, 2018TIME: 11:00am EDT, 5:00pm CEST The need to quantify urine is valuable because it provides information on chemicals that the body makes naturally, as well...
      Loading Comments...